SSGJ-709

· Shenyang Sunshine Pharmaceutical Co., LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SSGJ-709, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors [Phase 1]